Overview

This case study highlights how one health plan successfully implemented WNS-HealthHelp’s specialty-driven radiation oncology UM strategy that delivered measurable financial and operational impact across a 400,000 member Medicare population. The program achieved a 25% reduction in utilization compared to projected increases, generated approximately $1.7 million in spend impact in the first 12 months, and delivered $1.85 PMPM savings while reducing unnecessary variation across advanced radiation oncology modalities. 

The Challenge

The health plan identified radiation oncology as a growing area of concern due to increasing utilization trends and rising treatment costs across several high-cost modalities. Key challenges included:

• Escalating spend associated with advanced radiation oncology therapies
• Increasing variation in treatment pathways and provider ordering patterns
• Limited visibility into modality utilization trends
• Reducing unnecessary utilization without disrupting member access
• Aligning oncology management with evidence-based clinical guidelines

They recognized that a more clinically integrated UM model was needed to improve oversight, optimize treatment appropriateness, and support long-term cost goals.

The Solution

Partnering with WNS-HealthHelp on a comprehensive radiation oncology utilization management program focused on evidence-based clinical decision-making and specialty expertise. The program included management and review across multiple radiation oncology modalities, including:

• 2D/3D Radiation Therapy
• Intensity-Modulated Radiation Therapy (IMRT)
• Brachytherapy
• Proton Beam Therapy
• Stereotactic Radiation Therapy

Rather than relying solely on administrative controls, the strategy emphasized clinically appropriate care pathways, provider collaboration, and modality optimization based on patient-specific needs and nationally recognized treatment guidelines.

Core elements of the program included:

• Specialty Clinical Expertise: Cases were reviewed by clinicians with radiation oncology expertise to support more informed treatment evaluations and evidence-based decision-making.
• Evidence-Based Guidelines: Clinical pathways helped align utilization decisions with established standards of care while reducing unnecessary variation.
• Collaborative Provider Engagement: The program prioritized clinical dialogue and provider partnership to reduce abrasion and support more consistent treatment planning.
• Utilization Analytics and Trend Monitoring: Enhanced reporting and analytics improved visibility into utilization patterns and opportunities for ongoing optimization.

Outcomes

The program delivered significant reductions in utilization and meaningful financial savings across the Medicare population.

• 25% reduction in utilization compared to an anticipated increase of 1.0 per 1,000 members
• Approximately $1.7 million reduction in spend
• $1.85 PMPM savings
• Double-digit utilization reductions across all major radiation oncology modalities

Modality-Specific Impact